Ottawa has signed deals for millions of doses from 4 companies, and a 5th is close
The federal government announced agreements with Moderna and Pfizer/BioNTech on Aug. 5 and with Novavax and Janssen, a subsidiary of Johnson & Johnson, earlier this week.
It also said it's close to a deal with AstraZeneca, based in the United Kingdom.
All of the companies have received funding from the U.S. government's Operation Warp Speed, which is investing billions of dollars to fast-track the development of promising vaccine candidates.
Canada will receive 20 million to 76 million doses of each vaccine, should any of them successfully make it through clinical trials and be approved by Health Canada.